ARTICLE | Clinical News
Eravacycline regulatory update
April 7, 2014 7:00 AM UTC
Tetraphase said FDA granted Fast Track designation to both IV and oral formulations of antibiotic eravacycline. The company is evaluating the IV formulation in the Phase III IGNITE 1 trial to treat co...